Catalyst Pharmaceuticals (CPRX) Invested Capital (2010 - 2026)

Catalyst Pharmaceuticals (CPRX) has 17 years of Invested Capital data on file, last reported at $1.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 27.5% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 27.5% YoY), and the FY2025 full-year result was $954.3 million, up 31.15% from the prior year.
• Invested Capital for Q1 2026 stood at $1.0 billion, up from $954.3 million in the prior quarter.
• Across five years, Invested Capital topped out at $1.0 billion in Q1 2026 and bottomed at $220.2 million in Q1 2022.
• The 5-year median for Invested Capital is $561.4 million (2024), against an average of $563.1 million.
• The widest annual swing landed in 2022, when Invested Capital grew 23.27%; it then surged 89.63% in 2024.
• A 5-year view of Invested Capital shows it stood at $300.4 million in 2022, then rose by 29.11% to $387.9 million in 2023, then surged by 87.59% to $727.6 million in 2024, then jumped by 31.15% to $954.3 million in 2025, then climbed by 6.12% to $1.0 billion in 2026.
• The last three Invested Capital figures came in at $1.0 billion (Q1 2026), $954.3 million (Q4 2025), and $920.2 million (Q3 2025), per Business Quant data.

Peer Comparison